METASTATIC PROSTATE ADENOCARCINOMA
Clinical trials for METASTATIC PROSTATE ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation drug aims to slow bone tumors in advanced cancer
Disease control Not yet recruitingThis early-phase study tests a new drug (Sn-117m-DTPA) that delivers low-level radiation directly to bone tumors while being gentler on bone marrow. It is for people with prostate, breast, or lung cancer that has spread to the bones. The main goals are to find the safest dose and…
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:56 UTC
-
Could a longer break between doses improve life for men with advanced prostate cancer?
Disease control Not yet recruitingThis study is for men with advanced, hormone-resistant prostate cancer that has spread. It tests whether giving the targeted radiation drug lutetium-177 PSMA less often, based on how the cancer responds, can improve quality of life without shortening survival. About 1,500 partici…
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 26, 2026 10:53 UTC